PIII Other Current Liab from 2010 to 2024

PIII Stock  USD 0.21  0  1.43%   
P3 Health's Other Current Liabilities is increasing with slightly volatile movements from year to year. Other Current Liabilities is predicted to flatten to about 174.3 M. For the period between 2010 and 2024, P3 Health, Other Current Liabilities quarterly trend regression had mean deviation of  74,944,344 and range of 264.7 M. View All Fundamentals
 
Other Current Liabilities  
First Reported
2010-12-31
Previous Quarter
285.3 M
Current Value
174.3 M
Quarterly Volatility
91.9 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check P3 Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among P3 Health's main balance sheet or income statement drivers, such as Depreciation And Amortization of 91 M, Interest Expense of 16.8 M or Selling General Administrative of 87.6 M, as well as many indicators such as Price To Sales Ratio of 0.0932, Dividend Yield of 0.0 or PTB Ratio of 0.83. PIII financial statements analysis is a perfect complement when working with P3 Health Valuation or Volatility modules.
  
Check out the analysis of P3 Health Correlation against competitors.

Latest P3 Health's Other Current Liab Growth Pattern

Below is the plot of the Other Current Liab of P3 Health Partners over the last few years. It is P3 Health's Other Current Liabilities historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in P3 Health's overall financial position and show how it may be relating to other accounts over time.
Other Current Liab10 Years Trend
Slightly volatile
   Other Current Liab   
       Timeline  

PIII Other Current Liab Regression Statistics

Arithmetic Mean76,747,622
Geometric Mean41,875,916
Coefficient Of Variation119.75
Mean Deviation74,944,344
Median20,539,364
Standard Deviation91,905,661
Sample Variance8446.7T
Range264.7M
R-Value0.78
Mean Square Error3497.2T
R-Squared0.62
Significance0.0005
Slope16,123,374
Total Sum of Squares118253.1T

PIII Other Current Liab History

2024174.3 M
2023285.3 M
2022230.1 M
2021177.4 M
202078.7 M

About P3 Health Financial Statements

Investors use fundamental indicators, such as P3 Health's Other Current Liab, to determine how well the company is positioned to perform in the future. Although P3 Health's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Other Current Liabilities285.3 M174.3 M

Currently Active Assets on Macroaxis

When determining whether P3 Health Partners is a strong investment it is important to analyze P3 Health's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact P3 Health's future performance. For an informed investment choice regarding PIII Stock, refer to the following important reports:
Check out the analysis of P3 Health Correlation against competitors.
You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of P3 Health. If investors know PIII will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about P3 Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.86)
Revenue Per Share
11.552
Quarterly Revenue Growth
0.152
Return On Assets
(0.12)
Return On Equity
(0.41)
The market value of P3 Health Partners is measured differently than its book value, which is the value of PIII that is recorded on the company's balance sheet. Investors also form their own opinion of P3 Health's value that differs from its market value or its book value, called intrinsic value, which is P3 Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because P3 Health's market value can be influenced by many factors that don't directly affect P3 Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between P3 Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if P3 Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, P3 Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.